The many and varied restrictions around the world caused by COVID-19 have had a significant impact on clinical trials and the collection of data: some trials have failed to finish and others have been interrupted. The challenge now is not only how to manage potentially compromised data, but also how to effectively identify, monitor and mitigate risk for future trials.
During this hour-long panel discussion, we will explore the strategic and operational risks that have, and continue to, materialise in clinical trials as well as exploring trial resilience and how to stop future trials being disrupted by COVID-19.
tranScrip’s experts will be joined by other experts who will share their experiences.
We encourage attendees to comment and ask questions to make this an interactive discussion.
Date and time: Oct 8, 2020 2:00 PM – 3:00 PM CEST
Dedicated registration link here.